Beranda › Atrofi Sistem Multipel › Tennessee
Uji klinis Atrofi Sistem Multipel di Tennessee
8 studi untuk Atrofi Sistem Multipel mencari peserta di lokasi di Tennessee.
Kota di Tennessee
Teks studi resmi (Bahasa Inggris)
A Trial to Test if TEV-56286 is Effective for Treatment of Participants With Multiple System Atrophy
- Teva Investigational Site 15874, Nashville
Menerima pesertaFase 2
Usia 30 hingga 75 · Semua jenis kelamin · Diperbarui 20 Jul 2026 · NCT06568237Use of Accelerometer for Quantification of Neurogenic Orthostatic Hypotension Symptoms
- Autonomic Dysfunction Center/ Vanderbilt University Medical Center, Nashville
Menerima peserta
Usia 40 hingga 80 · Semua jenis kelamin · Diperbarui 2 Jul 2026 · NCT04782830Natural History Study of Synucleinopathies
- Vanderbilt Univeristy, Nashville
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Jun 2026 · NCT01799915CPAP for the Treatment of Supine Hypertension
- Autonomic Dysfunction Center/ Vanderbilt University Medical Center, Nashville
Menerima peserta
Usia 40 hingga 80 · Semua jenis kelamin · Diperbarui 7 Apr 2026 · NCT05489575[18F]F-DOPA Imaging in Patients With Autonomic Failure
- Vanderbilt University Medical Center, Nashville
Menerima pesertaFase 1Sukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Mar 2026 · NCT04246437Overnight Trials With Heat Stress in Autonomic Failure Patients With Supine Hypertension
- Autonomic Dysfunction Center/ Vanderbilt University Medical Center, Nashville
Menerima peserta
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 16 Jan 2026 · NCT03042988Treatment of Supine Hypertension in Autonomic Failure (CPAP)
- Autonomic Dysfunction Center/ Vanderbilt University Medical Center, Nashville
Menerima peserta
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 6 Nov 2025 · NCT03312556Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- Autonomic Dysfunction Center/ Vanderbilt University Medical Center, Nashville
Menerima pesertaFase 1
Usia 40 hingga 80 · Semua jenis kelamin · Diperbarui 14 Okt 2025 · NCT02897063Dari ClinicalTrials.gov, data diambil 3 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.